Bernhard Roth

Title: The Innovative Contributions of Bernhard Roth

Introduction

Bernhard Roth is a notable inventor based in Lahntal, Germany. He has made significant contributions to the field of virology through his innovative patents. With a total of 3 patents, Roth's work focuses on the detection and quantification of mammalian reoviruses, which are crucial for vaccine production processes.

Latest Patents

Roth's latest patents include methods for the detection of mammalian reoviruses. One of his inventions is a generic assay that utilizes reverse transcription (RT-PCR) real-time (q-PCR) techniques to amplify a conserved region within all MRV types. This method allows for the quantification of MRV RNA molecules, regardless of the specific virus type, such as MRV-1 or MRV-2. Another significant patent is the development of an exogenous internal positive control for contaminating viruses. This invention employs a second virus as an internal positive control to verify the reliability of assays designed to detect a primary virus, ensuring the absence of the first virus in biological or pharmaceutical samples.

Career Highlights

Throughout his career, Bernhard Roth has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Seqirus UK Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions for viral detection and vaccine production.

Collaborations

Roth has collaborated with notable professionals in his field, including Gerard Chan and Kevin Murphy. These partnerships have further enhanced his research and development efforts.

Conclusion

Bernhard Roth's contributions to the field of virology through his patents demonstrate his commitment to advancing medical science. His innovative methods for detecting mammalian reoviruses play a vital role in ensuring the safety and efficacy of vaccines.